Search over 3,000 reports

    BeneFIX- Drug Insights, 2017

    BeneFIX- Drug Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0146
    DelveInsight's pharmaceuticals report, " BeneFIX Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the BeneFIX covering the historical global sales and also provides the BeneFIX sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for BeneFIX and emerging therapies in this space.


    A review of the BeneFIX, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    BeneFIX- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    BeneFIX Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Table 1: BeneFIX, Description
    Table 2: BeneFIX, Product Details
    Table 3: BeneFIX, Historical Sales (in million USD)
    Table 4: BeneFIX, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: BeneFIX, Patent Details
    Table 6: Company, Overview
    Table 7: BeneFIX Major Competitors BeneFIX
    Table 8: Emerging Therapies
    Figure 1: BeneFIX, Historical Sales (in million USD)
    Figure 2: BeneFIX, Forecasted Sales from 2017-2019 (in million USD)
    Wyeth Biopharma
    hemorrhagic episodes in patients with hemophilia B
    congenital factor IX deficiency
    Christmas disease

    BeneFIX Marketed Drugs Overview
    BeneFIX Market Assessment
    BeneFIX API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    BeneFIX US DMF
    BeneFIX US Drug Master Files
    BeneFIX Active Substance Master File/ EUDMF
    BeneFIX Generic players
    BeneFIX Patent Expiration
    BeneFIX Patent Exclusivity
    BeneFIX API Manufacturers
    BeneFIX Global Forecasted Sales Figure
    BeneFIX API Route of Synthesis
    BeneFIX Market sales
    BeneFIX SWOT Analysis
    BeneFIX Pipeline
    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap